Same Drug Class

Metoprolol vs Propranolol

Overview

Metoprolol is a beta-1 selective (cardioselective) beta-blocker, while propranolol is a non-selective beta-1 and beta-2 antagonist — the prototype beta-blocker. This selectivity difference is clinically significant in patients with asthma, COPD, or diabetes.

Mechanism of Action

Metoprolol blocks beta-1 receptors selectively. Propranolol blocks both beta-1 and beta-2 receptors with equal affinity. Beta-2 blockade in the lungs can cause bronchoconstriction; in the pancreas, it can mask tachycardia (a warning sign of hypoglycemia) and impair glycogenolysis.

Pharmacokinetics

Propranolol has high lipophilicity, ~90% first-pass metabolism by CYP1A2 and CYP2D6, bioavailability only ~25–30%, and a short half-life of 3–6 h (requiring dosing 2–3× daily for IR formulation). An LA formulation extends coverage. Propranolol readily crosses the CNS.

Metoprolol IR has bioavailability ~50%, half-life 3–7 h (CYP2D6-dependent). Metoprolol succinate XL provides 24-h coverage. Both are lipophilic.

Pharmacodynamics and Indications

Propranolol has uniquely broad indications: hypertension, angina, arrhythmias, post-MI, hypertrophic cardiomyopathy, essential tremor, thyrotoxicosis (peri-operative), migraine prophylaxis, portal hypertension, infantile hemangiomas (off-label). Its non-selective beta-blockade is especially useful in conditions driven by excess sympathomimetic tone across all tissues.

Metoprolol's cardioselectivity makes it preferred in cardiac patients who also have reactive airway disease.

Safety in Asthma/COPD

Propranolol is contraindicated in asthma and COPD due to beta-2 blockade causing bronchospasm. Metoprolol at standard doses can be cautiously used in mild COPD but should be monitored. Even cardioselective beta-blockers lose selectivity at higher doses.

Key Takeaways

  • Propranolol: non-selective, broad indications, first-line for tremor/thyrotoxicosis/portal HTN/migraine
  • Metoprolol: cardioselective, preferred in asthma/COPD, HFrEF (XL formulation)
  • Both lipophilic with CNS side effects; propranolol has higher first-pass extraction

Fazit

Propranolol is indicated when non-selective beta-blockade is needed (essential tremor, thyrotoxicosis, portal hypertension, certain arrhythmias). Metoprolol is preferred for cardiac indications (HFrEF, post-MI rate control, hypertension) especially in patients with pulmonary disease.